SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-14-073749
Filing Date
2014-12-12
Accepted
2014-12-12 16:54:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3 v396333_s3.htm S-3 147976
2 EXHIBIT 5 v396333_ex5.htm EX-5 8003
3 EXHIBIT 23.1 v396333_ex23-1.htm EX-23.1 2774
  Complete submission text file 0001144204-14-073749.txt   159849
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-200927 | Film No.: 141284207
SIC: 2836 Biological Products, (No Diagnostic Substances)